Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval For Treatment Of Peripheral Neuropathic Pain In Japan
Links shared publicly online about this topic.
- 764total visits
Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval For Treatment Of Peripheral Neuropathic Pain In Japan
View full resource at medicalnewstoday.com
Tags: Seizure Medication, Fibromyalgia Medication, Neuropathic Pain Medication, Neuropathic Pain, Lyrica, Pfizer, Epilepsy Medication
Most Recently Shared on October 30, 2010 at 5:05 pm By:
Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval For Treatment Of Peripheral Neuropathic Pain In Japan http://mnt.to/3LTK
Also Shared By:
New Drug for Rheumatoid Arthritis Favored by FDA Panel - Yahoo! News
news.yahoo.com — “From Yahoo! News: For those who have rheumatoid arthritis and are just not getting any benefits from their current treatment regimen, there could be hope on the horizon. A major drug company, Pfizer, has developed a new drug that has received FDA panel favor. This does not mean that the FDA will definitely approve it.” View full resource at news.yahoo.com
Most Recently Shared on May 12, 2012 at 7:44 am By:
New Drug for Rheumatoid Arthritis Favored by FDA Panel: For those who have rheumatoid arthritis and are just not... http://t.co/QmqUK6js
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
pharmaceuticalonline.com — “Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend” View full resource at pharmaceuticalonline.com
Most Recently Shared on May 12, 2012 at 7:07 am By:
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severe... http://t.co/soPAIfWQ
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug - Health News - redOrbit
redorbit.com — “An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.” View full resource at redorbit.com
Most Recently Shared on May 11, 2012 at 7:41 pm By:
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug: Connie K. Ho for http://t.co/6eqBD5l3 An adv... http://t.co/d6SkusIQ
Bosutinib Buyer Beware | Chemical & Engineering News
cen.acs.org — “Bosutinib Buyer Beware | Chemical & Engineering News” View full resource at cen.acs.org
Most Recently Shared on May 11, 2012 at 4:47 pm By:
Buyer Beware: "Bad" bosutinib (an isomer) been going around. None to patients, Pfizer says. But damaging to research. http://t.co/XT4ORYCS
FDA Panel in Favor of First JAK Inhibitor for RA
painlive.com — “The FDA Arthritis Advisory Committee voted to recommend approval of tofacitinib, a new treatment for moderate to severe rheumatoid arthritis (RA), Pfizer announced.” View full resource at painlive.com
Most Recently Shared on May 11, 2012 at 4:00 pm By:
FDA Panel in Favor of First JAK Inhibitor for RA http://t.co/rlqs8u3o
NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments | Highlight HEALTH
highlighthealth.com — “Scientists will gain access to select compounds from Pfizer, AstraZeneca and Lilly.” View full resource at highlighthealth.com
Most Recently Shared on May 11, 2012 at 6:38 am By:
Walter Jessen, PhD Pharma, Research, PhD, Active Health Library, and Doctor
NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments http://t.co/9VJ9vUnn
NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments | Highlight HEALTH
feeds.feedblitz.com — “Scientists will gain access to select compounds from Pfizer, AstraZeneca and Lilly.” View full resource at feeds.feedblitz.com
Most Recently Shared on May 11, 2012 at 12:32 am By:
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on May 10, 2012 at 3:57 pm By:
Pfizer stops promoting Lipitor in US http://t.co/N85eH3hU
Medical News: Pfizer's Arthritis Pill Gets Nod from FDA Panel - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “Medical News: Pfizer's Arthritis Pill Gets Nod from FDA Panel - in Rheumatology, Arthritis from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on May 10, 2012 at 1:10 pm By:
#Pfizer's #Arthritis Pill Gets Nod from #FDA Panel http://t.co/zFHgaqMh
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval - NYTimes.com
nytimes.com — “A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.” View full resource at nytimes.com
Most Recently Shared on May 10, 2012 at 1:09 pm By:
Dr. Shashank Akerkar Doctor, Internist, Rheumatologist, and Physician
#Arthritis Pill From Pfizer Wins Support Of U.S. Panel http://t.co/hm0jHkP1 #rheum
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval - NYTimes.com
nytimes.com — “A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.” View full resource at nytimes.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval: A federal advisory panel recommended approval ... http://t.co/s1MJUD0v
FDA panel favors Pfizer's new arthritis drug - Health - Aging - msnbc.com
msnbc.msn.com — “Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects.” View full resource at msnbc.msn.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
Panel backs new arthritis drug: >> michael collins , a former trader on the chicago commodities exchange , is in... http://t.co/dcO2IvI0
FDA panel urges approval for Pfizer arthritis drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.” View full resource at news.yahoo.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
FDA panel urges approval for Pfizer arthritis drug: An advisory committee to the US Food and Drug Administration... http://t.co/FlnNPjEd
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval - NYTimes.com
nytimes.com — “A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.” View full resource at nytimes.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
Panel Supports Arthritis Pill: A federal advisory panel recommended approval of a rheumatoid arthritis pill, but... http://t.co/i6uv7JNq
FDA panel favors novel arthritis drug from Pfizer - Yahoo! News
news.yahoo.com — “From Yahoo! News: Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects.” View full resource at news.yahoo.com
Most Recently Shared on May 10, 2012 at 12:29 am By:
FDA panel favors novel arthritis drug from Pfizer: Federal health advisers said Wednesday that a first-of-a-kind... http://t.co/lnXhMmOv
Advertisement
medical_tweets
@medical_tweets
Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval For Treatment Of Peripheral Neuropathic Pain In Japan Pfize.. http://dld.bz/4kxV
1 year ago...